Vanguard Group Inc Verve Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,331,312 shares of VERV stock, worth $32.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,331,312
Previous 5,471,930 15.71%
Holding current value
$32.9 Million
Previous $76.3 Million 10.23%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$10.81 - $17.96 $9.29 Million - $15.4 Million
859,382 Added 15.71%
6,331,312 $84.1 Million
Q4 2023

Feb 14, 2024
BUY
$8.84 - $18.7 $5.65 Million - $11.9 Million
638,962 Added 13.22%
5,471,930 $76.3 Million
Q3 2023

Nov 14, 2023
BUY
$11.42 - $20.82 $8.47 Million - $15.4 Million
741,753 Added 18.13%
4,832,968 $64.1 Million
Q2 2023

Aug 14, 2023
BUY
$13.34 - $19.9 $2.83 Million - $4.23 Million
212,365 Added 5.47%
4,091,215 $76.7 Million
Q1 2023

May 15, 2023
BUY
$14.3 - $24.01 $955,611 - $1.6 Million
66,826 Added 1.75%
3,878,850 $55.9 Million
Q4 2022

Feb 10, 2023
BUY
$17.85 - $40.7 $2.73 Million - $6.24 Million
153,212 Added 4.19%
3,812,024 $73.8 Million
Q3 2022

Nov 14, 2022
BUY
$15.63 - $41.49 $20.6 Million - $54.6 Million
1,316,619 Added 56.21%
3,658,812 $126 Million
Q2 2022

Aug 12, 2022
BUY
$11.14 - $23.17 $260,876 - $542,595
23,418 Added 1.01%
2,342,193 $35.8 Million
Q1 2022

May 13, 2022
BUY
$20.92 - $39.36 $20 Million - $37.6 Million
954,554 Added 69.97%
2,318,775 $52.9 Million
Q4 2021

Feb 14, 2022
BUY
$31.94 - $54.82 $2.61 Million - $4.48 Million
81,679 Added 6.37%
1,364,221 $50.3 Million
Q3 2021

Nov 12, 2021
BUY
$46.0 - $73.99 $56 Million - $90.1 Million
1,217,542 Added 1873.14%
1,282,542 $60.3 Million
Q2 2021

Aug 13, 2021
BUY
$31.92 - $60.25 $2.07 Million - $3.92 Million
65,000 New
65,000 $3.92 Million

Others Institutions Holding VERV

# of Institutions
169
Shares Held
78.3M
Call Options Held
125K
Put Options Held
185K
View Full List

About Verve Therapeutics, Inc.

VERV Quotes by TradingView
  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $311M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email